Technology News and Research

RSS
Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

A.D.A.M. announces new online education product for K-12 market

A.D.A.M. announces new online education product for K-12 market

LAB Research completes research and development program that involves pulmonary monitoring system

LAB Research completes research and development program that involves pulmonary monitoring system

Use of technology that expands access to qualified radiologist leads to earlier diagnosis and treatment of breast cancer

Use of technology that expands access to qualified radiologist leads to earlier diagnosis and treatment of breast cancer

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

MicroCHIPS raises $16.5 million to fund for diabetes and osteoporosis programs

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Urologists use robot-assisted surgery to cut off average surgery time for vasectomy reversal

Urologists use robot-assisted surgery to cut off average surgery time for vasectomy reversal

Center for Attention Deficit and Learning Disorders adds HEG to its list of treatment options

Center for Attention Deficit and Learning Disorders adds HEG to its list of treatment options

Medsphere Systems announces new partnerships to promote EHR systems in healthcare facilities

Medsphere Systems announces new partnerships to promote EHR systems in healthcare facilities

NEB introduces Lemo21(DE3) Competent E. coli

NEB introduces Lemo21(DE3) Competent E. coli

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Proteostasis Therapeutics enters into exclusive license agreement with New York University

Nation's best cardiac programs team up to offer improved heart care

Nation's best cardiac programs team up to offer improved heart care

UK-based Andromeda Capital invests 1.25 million in TheraSim

UK-based Andromeda Capital invests 1.25 million in TheraSim

Hi-Tech Pharmacal receives clearance from FDA to market Tropazone lotion

Hi-Tech Pharmacal receives clearance from FDA to market Tropazone lotion

ICSI creates Professional Partnerships group to help medical groups transform their health care

ICSI creates Professional Partnerships group to help medical groups transform their health care

Gore's next generation Conformable GORE TAG Thoracic Endoprosthesis enters clinical trial

Gore's next generation Conformable GORE TAG Thoracic Endoprosthesis enters clinical trial

Lawson Software agrees to acquire Healthvision Solutions through the acquisition of Quovadx Holdings

Lawson Software agrees to acquire Healthvision Solutions through the acquisition of Quovadx Holdings

Misonix signs new distribution agreement with Varlix Mexico

Misonix signs new distribution agreement with Varlix Mexico

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.